Atlantic Lithium (A11:AU) has announced Leadership Streamlining and Cost Reductions
Download the PDF here.
This post appeared first on investingnews.com
CSE:NF
OTCQX:NFUNF
Nuclear Fuels Inc. (CSE: NF) (OTCQX: NFUNF) (‘Nuclear Fuels’ or the ‘Company ‘) announces the commencement of its 2025 drilling program, with an initial plan for at least 100,000 feet, at the Kaycee Uranium Project (‘the Project’) located in the Powder River Basin (‘PRB’) of Wyoming . The regional drilling conducted in late 2024 successfully identified two new zones of roll front-hosted uranium mineralization. Notably, the Outpost and Trail Dust Zones were discovered during the late stages of the 2024 program, and the Company is excited to follow up on these promising new areas during the 2025 drill program.
Highlights from the 2024 Regional Exploration Program ( Nuclear Fuels NR January 29, 2025 ) :
- Drill hole LT24_050 returned 0.082% eU 3 O 8 over 6.5 feet for a total grade thickness (‘GT’) of 0.532, beginning at a downhole depth of 767.0 feet at the Outpost Zone;
- At the Trail Dust Zone, located approximately 1.5 miles to the north of the Outpost Zone, drill hole LT24_037 returned 0.0553% eU 3 O 8 over 5.5 feet for a total hole GT of 0.304, beginning at a downhole depth of 886.0 feet;
- The 2025 exploration program is now underway at the Project and will follow up on these results, as well as test other high priority targets;
- This fully-funded exploration program consists of an initial 100,000 feet of rotary mud drilling, with results to be reported at a similar cadence to the 2024 drill program.
‘Our 2025 drill program is designed to build on the discovery of the Outpost Zone and further test the potential of the Kaycee Project,’ said Greg Huffman , Chief Executive Officer. ‘This new zone of roll front-hosted uranium mineralization not only validates our geological model but also highlights the potential for further discoveries within this district. As we commence our 2025 drilling campaign, our priority is to delineate the extent of the Outpost Zone and assess its potential to contribute to future resources at Kaycee . We remain committed to advancing the Kaycee Project and delivering value to our shareholders through systematic exploration and development.’
Strategic Transaction with Premier American Uranium Inc.
On June 5, 2025 the Company and Premier American Uranium Inc. (TSXV: PUR, OTCQB: PAUIF) announced that they have entered into an arm’s length definitive agreement ( Nuclear Fuels NR June 5, 2025 ), pursuant to which Premier American Uranium has agreed to acquire all of the issued and outstanding common shares of Nuclear Fuels by way of a court-approved plan of arrangement (the ‘Arrangement’ or the ‘Transaction’). Under the terms of the Arrangement, shareholders of Nuclear Fuels will receive 0.33 of a common share of Premier American Uranium for each Nuclear Fuels Share held. Existing shareholders of Premier American Uranium and Nuclear Fuels will own approximately 59% and 41% (on a basic shares outstanding basis), respectively, of the pro forma outstanding PUR Shares on closing of the Arrangement. The Transaction will require approval by at least 66 2/3% of the votes cast by NF Shareholders and, if required by Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions, a simple majority of the votes cast by Nuclear Fuels Shareholders excluding certain interested or related parties, in each case by shareholders present in person or represented by proxy at a special meeting of NF Shareholders to be called in connection with the Transaction (the ‘NF Special Meeting’). The NF Special Meeting is expected to be held in the third quarter of 2025 and Closing of the Transaction is anticipated to occur in the third quarter of 2025.
Kaycee Uranium Project, Wyoming
The Kaycee Project in Wyoming’s PRB, Nuclear Fuels’ priority project, consists of 55 square miles of mineral rights over a 35-mile mineralized trend hosting 430 miles of identified roll fronts. The Kaycee Project is believed to be the only project in the PRB where all three known historically productive sandstone formations (Wasatch, Fort Union, and Lance) are mineralized and potentially accessible for ISR extraction. The Kaycee Project, under Nuclear Fuels, represents the first time since the early 1980’s that the entire district is controlled by one company.
In 2023, Nuclear Fuels acquired the Kaycee Project from enCore Energy Corp., which retains a back-in right for 51% of the project by paying 2.5X the exploration costs and financing the Kaycee project to production (costs recoverable from production) upon Nuclear Fuels establishing a minimum 15 million pound eU 3 O 8 43-101 compliant resource.
Wyoming is a proven and prolific uranium producer with a pro-energy government and established regulatory regime for the permitting and extraction of uranium through ISR technology. Wyoming is one of the few ‘Agreement States’ hosting ISR uranium deposits, where the federal government and the Nuclear Regulatory Commission have ceded regulatory authority to the state government, permitting and advancing uranium projects is more efficient and streamlined as compared to most other states. Wyoming , with over 250 million pounds of historic uranium production, ranks as the state with the second most uranium production to date; most of which has been through the ISR technology since 1990, predominantly from the PRB.
The technical content of this news release has been reviewed and approved by Mark Travis , CPG., a contractor to the Company, and a Qualified Person as defined in National Instrument 43-101.
About Nuclear Fuels Inc.
Nuclear Fuels Inc. is a uranium exploration company advancing early-stage, district-scale In-Situ Recovery (‘ISR’) amenable uranium projects towards production in the United States of America . Leveraging extensive proprietary historical databases and deep industry expertise, Nuclear Fuels is well-positioned in a sector poised for significant and sustained growth on the back of strong government support. Nuclear Fuels has consolidated the Kaycee district under single-company control for the first time since the early 1980s. Currently executing its 2025 drill program following successful 2023 and 2024 drilling, the Company aims to expand on historic resources across a 35-mile trend with over 430 miles of mapped roll-fronts defined by 3,800 drill holes. The Company’s strategic relationship with enCore Energy Corp., America’s Clean Energy Company, offers a mutually beneficial ‘pathway to production,’ with enCore owning an equity interest and retaining the right to back-in to 51% ownership in the flagship Kaycee Project in Wyoming’s prolific Powder River Basin.
Forward-Looking Information
The Canadian Securities Exchange has not reviewed this press release and does not accept responsibility for the adequacy or accuracy of this news release.
Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as ‘may’, ‘should’, ‘anticipate’, ‘expect’, ‘potential’, ‘believe’, ‘intend’ or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements relating to planned exploration programs and the results of additional exploration work in seeking to establish mineral resources as defined in NI43-101 on any of our properties. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with the completing planned exploration programs and the results of those programs; the ability to access additional capital to fund planned and future operations; regulatory risks including exploration permitting; risks associated with title to our mineral projects; the ability of the company to implement its business strategies; and other risks including risks contained in documents available for review at www.sedar.com under the Company’s profile. Readers are cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
View original content to download multimedia: https://www.prnewswire.com/news-releases/nuclear-fuels-commences-2025-kaycee-uranium-project-drill-program-302478347.html
SOURCE Nuclear Fuels Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2025/11/c2680.html
News Provided by Canada Newswire via QuoteMedia
This post appeared first on investingnews.com
Radiopharm Theranostics (ASX:RAD, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for RAD101 to distinguish between recurrent disease and treatment effect of brain metastases originating from solid tumors of different origin including leptomeningeal disease.
RAD101 is the Company’s novel imaging small molecule that targets fatty acid synthase (FASN), a multi-enzyme protein that catalyses fatty acid synthesis and is overexpressed in many solid tumors, including cerebral metastases.
‘The FDA’s Fast Track Designation for RAD101 highlights the seriousness of recurrent brain metastases as a condition and the unmet medical need for innovative products that can differentiate between tumor recurrence and radiation necrosis or pseudprogression,’ said Riccardo Canevari, CEO and Managing Director of Radiopharm Theranostics. ‘RAD101 represents a promising advancement in improving diagnostic precision for brain metastases, offering hope for more effective clinical decision-making in the over 300,000 patients diagnosed annually in the U.S. We are excited to advance our Phase 2 clinical trial and anticipate sharing topline results in the second half of 2025.’
The FDA’s Fast Track designation is designed to facilitate the development and expedite the review of drugs that are intended to treat serious or life-threatening conditions and demonstrate the potential to address an unmet medical need. A Sponsor that receives Fast Track designation may be eligible for more frequent meetings and communications with the FDA and rolling review of any application for marketing approval. A Sponsor’s drug receiving Fast Track designation also may be eligible for Priority Review if relevant criteria are met.
About the Phase 2 Clinical Trial of RAD101
The U.S. multicenter, open-label, single arm Phase 2b clinical trial is evaluating the diagnostic performance of 18F-RAD101 in 30 individuals with confirmed recurrent brain metastases from solid tumors of different origins. The primary objective of the study is concordance between 18F-RAD101 positive lesions and those seen in conventional imaging (MRI with gadolinium) in participants with suspected recurrent brain metastases. Secondary endpoints are accuracy, sensitivity and specificity of RAD101 in identifying tumor recurrence versus radiation necrosis in previously stereotactic radiosurgery (SRS)-treated brain metastases.
About RAD101
RAD101 is the Company’s novel imaging small molecule that targets fatty acid synthase (FASN), a multi-enzyme protein that catalyses fatty acid synthesis and is overexpressed in many solid tumors, including cerebral metastasis. Targeting FASN activity may allow for the more accurate detection of cancer cells, representing a clinically relevant method for the imaging of brain metastases. Positive data from the Imperial College of London’s Phase 2a imaging trial of 18F-RAD101 in patients with brain metastases (both SRS pre-treated and treatment naïve patients) showed significant tumor uptake that was independent from the tumor of origin. The study further indicated that PET-MRI may potentially represent a non-invasive prediction of overall-survival, warranting larger studies.
About Radiopharm Theranostics
Radiopharm Theranostics is a clinical stage radiotherapeutics company developing a world-class platform of innovative radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. Radiopharm is listed on ASX (RAD) and on NASDAQ (RADX). The company has a pipeline of distinct and highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase 2 and three Phase 1 trials in a variety of solid tumor cancers including lung, breast, and brain metastases. Learn more at radiopharmtheranostics.com .
Authorised on behalf of the Radiopharm Theranostics board of directors by Chairman Paul Hopper.
For more information:
Riccardo Canevari
CEO & Managing Director
P: +1 862 309 0293
E: rc@radiopharmtheranostics.com
Anne Marie Fields
Precision AQ (Formerly Stern IR)
E: annemarie.fields@precisionaq.com
Paul Hopper
Executive Chairman
P: +61 406 671 515
E: paulhopper@lifescienceportfolio.com
Media
Matt Wright
NWR Communications
P: +61 451 896 420
E: matt@nwrcommunications.com.au
News Provided by GlobeNewswire via QuoteMedia
This post appeared first on investingnews.com
Traders have received a major boost following the latest US CPI data release, which came in lower than expectations. Now, these market participants are betting that there could be two Fed rate cuts, starting from the FOMC meeting in September. Traders Bet On Two Fed Rate Cuts In 2025 CME FedWatch data shows that traders
The post Traders Price In Two Fed Rate Cuts This Year Following US CPI Data appeared first on CoinGape.
Sandeep Nailwal:- In a big update coming from the Polygon co-founder himself, Sandeep Nailwal has stepped into the role of CEO of Polygon Foundation. The foundation oversees the blockchain’s multiple entities including Polygon Labs, Polygon Grants & Ecosystem Funds and provides support and funding for for Polygon’s blockchain protocols. While making the announcement, Sandeep Nailwal
The post Polygon Appoints Sandeep Nailwal as Foundation CEO to Lead AggLayer and Ecosystem Growth appeared first on CoinGape.
Dogecoin (DOGE) price rose for the third consecutive day, retesting the resistance level at $0.20 for the first time since May 30. Its rise continued slightly after Elon Musk expressed some regrets on some of his X posts about Trump. Let’s explore whether momentum will trigger an explosive rally, potentially to $0.2600, its highest point
The post Dogecoin Price at $0.2, Will Momentum Trigger an Explosive Rally? appeared first on CoinGape.
Crypto market has reacted positively as the US and Chinese officials have agreed to restore a truce, after two months of Trump’s tariff war and intense discussions in London over the past two days. The two largest economies agreed to enter the Pre-Liberation Day status quo. Amid this US-China deal, Bitcoin price trades around $110K,
The post Crypto Market Reacts as U.S.-China Deal Sparks Risk-On Rally Across Assets appeared first on CoinGape.
The U.S. Bureau of Labor Statistics will release the CPI data today, June 11, at 8:30 AM ET. As the netizens and investors brace for the May Consumer Price Index release, the market is on the edge, and higher volatility could form, depending on the outcome. Although investors’ sentiments are currently showing greed, the performance
The post What to Expect from the US CPI Release Today: Data Over 2.5% Could Crash Crypto Market appeared first on CoinGape.
LONDON — Wherever Nvidia CEO Jensen Huang goes, excitement follows — this time, all the way to London Tech Week.
The Nvidia boss — whom Wedbush analyst Daniel Ives dubs the “godfather of AI” — is more like a rockstar these days, given his wide-spanning effect on the AI industry.
“The amount of infrastructure required for AI wouldn’t be possible without that man,” one attendee at London Tech Week said.
“He’s like Iron Man,” the attendee added, referencing the popular Marvel superhero who is a tech billionaire inventor under the name of Tony Stark.
The lines to get into the Olympia auditorium were already building around 40 minutes before Jensen was set to take the stage alongside U.K. Prime Minister Keir Starmer. Not everyone managed to get in — but there were helpfully screens around the venue where people could catch a glimpse of Huang’s talk.
The Nvidia CEO gave his continued bullish assessment of artificial intelligence, calling it an “incredible technology” and saying it should be seen as infrastructure, just like electricity.
There weren’t any multi-billion-dollar investments touted at London Tech Week. But the biggest win for Starmer and the U.K. by far was Huang’s lavish praise for the country.
Wearing his trademark leather jacket, Huang called the U.K. the “envy of the world” that is in the midst of a “Goldilocks circumstance,” boasting a vibrant venture capital ecosystem, as well as budding AI entrepreneurs from leading firms including Google DeepMind, Synthesia, Wayve and ElevenLabs.
Speaking alongside Huang, Starmer spoke in an animated manner as he touted Nvidia’s investments in the U.K. Earlier in the day, the U.S. chipmaker announced a new “U.K. sovereign AI industry forum,” as well as commitments from cloud vendors Nscale and Nebius to deploy new facilities containing thousands of its Blackwell GPU chips.
Starmer spoke at length about AI’s promise and the ways in which it could ease the burdens faced by the U.K.’s public sector institutions, from hospitals to schools.
Huang added that the U.K. is “such a great place to invest,” noting that Nvidia plans to partner with the country to upskill tech workers and build out domestic AI infrastructure.
“Infrastructure enables more research — more research, more breakthroughs, more companies,” the Nvidia chief said. “That flywheel will start taking off. It’s already quite large, but we’re just going to get that flywheel going.”
Starmer thanked Huang for his point, commenting that “the confidence it gives when you explain it that way is huge.”
“From our point of view, we’re really pleased to be seen that way,” the U.K. leader said.
The pair shook hands at the end.
Altogether, there was a lot of energy in the room. Huang said he was “excited” for London Tech Week, and he was met with a round of applause from the audience.
Huang has become the CEO everyone wants to be seen with. Nvidia has positioned itself as central to the AI revolution, which many commentators say is in the early innings.
Nvidia wants that revolution to be built on its chips. And for countries like the U.K., these moments provide a chance for the country to tout its investment potential and for its leader to publicly share a stage with the man seen as powering the AI push.
London was Huang’s first stop in a broader European tour.
The Nvidia boss will travel to Paris later this week, where the chipmaker will host its GTC conference. Politicians including President Emmanuel Macron, who has driven France’s ambition to become a European AI hub, will also likely want some face time with Huang.
This post appeared first on NBC NEWS
Chipotle Mexican Grill is hoping that Americans’ love for ranch will boost its sales.
On June 17, the burrito chain is launching Adobo Ranch, a spicier take on the iconic condiment that has transcended salads to adorn pizza, chicken wings and chips. The menu item is Chipotle’s first new dip since queso blanco, which launched in 2020.
The debut comes as Chipotle tries to recover from a rough start to the year. In the first quarter, the company reported its first same-store sales decline since 2020. Executives cited a pullback from consumers who had become more concerned about the economy.
The company also lowered the top end of its outlook for full-year same-store sales growth and said traffic wouldn’t grow until the second half of the year.
Shares of Chipotle have fallen 12% this year, dragging its market cap down to $71 billion.
But Adobo Ranch could help to boost the company’s sales if it draws cautious diners back to the chain’s restaurants.
The dipping sauce is made with adobo peppers, sour cream and herbs and spices, according to the company. Adding Adobo Ranch to an order will cost an extra 75 cents.
Ranch outsells ketchup, although NIQ retail sales data shows that mayo still holds the top spot as the favorite condiment of U.S. consumers.
This post appeared first on NBC NEWS